- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.09. | RespireRx Pharmaceuticals Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| RESPIRERX Aktie jetzt für 0€ handeln | |||||
| 02.08. | RespireRx Pharmaceuticals Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | RespireRx Pharmaceuticals Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.05. | RespireRx Pharmaceuticals Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.05. | RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, its Lead AMPAkine, to Improve Bladder Function in Patients with Spinal Cord Injury | 1 | GlobeNewswire (USA) | ||
| 20.03. | RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury | 122 | GlobeNewswire (Europe) | Glen Rock, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) ("RespireRx"or the"Company"), focused on the discovery and development of innovative and... ► Artikel lesen | |
| 13.02. | RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine | 256 | GlobeNewswire (Europe) | Glen Rock, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and... ► Artikel lesen | |
| 04.01. | RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient | 229 | GlobeNewswire (Europe) | Glen Rock, N.J., Jan. 04, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and... ► Artikel lesen | |
| 11.12.23 | RespireRX Pharmaceuticals Inc.: RespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development | 248 | GlobeNewswire (Europe) | Glen Rock, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) ("RespireRx" or the "Company"), a biopharmaceutical company focused on the discovery and development... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,003 | -25,00 % | CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO) | Toronto, Ontario--(Newsfile Corp. - Le 24 mai/May 2024) - Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading. The Company has rectified the situation that gave rise... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 31,690 | 0,00 % | Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 12-Month Low on Insider Selling | ||
| SINOPHARM | 2,494 | -3,37 % | Sinopharm Group-Aktie mit Kursverlusten (2,475 €) | Im Wertpapierhandel notiert das Wertpapier der Sinopharm Group zur Stunde leichter. Der jüngste Kurs betrug 2,48 Euro. Für Inhaber der Sinopharm Group ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
| CSPC PHARMA | 0,620 | -2,18 % | M Stanley Cuts CSPC PHARMA TP to $6.6 w/ Lower EPS Forecasts | ||
| ORAMED PHARMACEUTICALS | 2,098 | -2,42 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt | NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery... ► Artikel lesen | |
| ADASTRA | 0,457 | +0,44 % | Adastra Holdings Ltd.: Adastra Holdings Announces Sale of Perceive MD | Langley, British Columbia--(Newsfile Corp. - November 6, 2024) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 14,845 | -3,88 % | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | ||
| SELLAS LIFE SCIENCES | 1,132 | -3,41 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update | - Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapsed/Refractory... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 305,30 | +1,39 % | Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra | ||
| CATALYST PHARMACEUTICALS | 20,090 | +0,10 % | Vorstandsvorsitzender von Catalyst Pharmaceuticals verkauft Aktien im Wert von 3,1 Millionen US-Dollar | ||
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule enterss contract manufacturing deal | ||
| NUMINUS WELLNESS | 0,020 | -24,63 % | Numinus Applies for Management Cease Trade Order | ||
| BAYER | 19,550 | +0,03 % | Aurubis, Bayer, Evonik, Rheinmetall, ThyssenKrupp, Verbio u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen |
Das Unternehmen RESPIRERX PHARMACEUTICALS INC kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RESPIRERX PHARMACEUTICALS INC finden Sie auf Wallstreet Online.
